News & Updates

Show Multimedia Only
Statin-ezetimibe combo superior to monotherapy in preventing CVD in T2D patients
Statin-ezetimibe combo superior to monotherapy in preventing CVD in T2D patients
27 Jun 2024

In patients with type 2 diabetes (T2D), moderate-intensity statin in combination with ezetimibe results in greater reductions in low-density lipoprotein cholesterol (LDL-C) and better prevention of adverse outcomes when compared with high-intensity statin monotherapy, suggests a study.

Statin-ezetimibe combo superior to monotherapy in preventing CVD in T2D patients
27 Jun 2024
Self-testing of HbA1c feasible in diabetic patients
Self-testing of HbA1c feasible in diabetic patients
26 Jun 2024 byStephen Padilla

Patients with diabetes show high levels of acceptance and ability to adopt self-testing of glycated haemoglobin (HbA1c) despite facing issues in the insertion of test cartridges into the analyser, reports a study. Patients also express willingness to do self-testing in the future if such a service is available.

Self-testing of HbA1c feasible in diabetic patients
26 Jun 2024
Off-label targeted drugs improve survival in CTEPH
Off-label targeted drugs improve survival in CTEPH
26 Jun 2024

Off-label pulmonary arterial hypertension (PAH)-targeted drugs may increase long-term survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH), as shown in a study.

Off-label targeted drugs improve survival in CTEPH
26 Jun 2024